Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis

Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis

IntroductionPasireotide (PAS) is a novel somatostatin receptor ligands (SRL), used in controlling hormonal hypersecretion in both acromegaly and Cushing’s Disease (CD). In previous studies and meta-analysis, first-generation SRLs were reported to be able to induce significant tumor shrinkage only in...

Full description

Bibliographic Details
Main Authors: Alessandro Mondin, Renzo Manara, Giacomo Voltan, Irene Tizianel, Luca Denaro, Marco Ferrari, Mattia Barbot, Carla Scaroni, Filippo Ceccato
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Endocrinology
Subjects:
pasireotide
cushing
acromegaly
tumor volume
tumor size
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.935759/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2022.935759/full

Similar Items